Evidence map›Paper›PMID 40884665›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Sperm DNA Fragmentation as a Marker of Chromoanagenesis Occurrence During Spermatogenesis.

Frédéric Morel, Margaux Sellier, Corinne Tous, Séverine Commet, Nadia Gueganic, Nathalie Douet-Guilbert, Benjamin Ganne, Vincent Gatinois, Franck Pellestor, Aurore Perrin

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Frédéric MorelService de Génétique Médicale et Biologie de la Reproduction, CHU de Brest, Brest, France. frederic.morel@chu-brest.fr.
Margaux SellierService de Génétique Médicale et Biologie de la Reproduction, CHU de Brest, Brest, France.
Corinne TousService de Génétique Médicale et Biologie de la Reproduction, CHU de Brest, Brest, France.
Séverine CommetFaculté de Médecine et des Sciences de la Santé, Université de Brest, EFS, UMR1078, GGB, Brest, France.
Nadia GueganicFaculté de Médecine et des Sciences de la Santé, Université de Brest, EFS, UMR1078, GGB, Brest, France.
Nathalie Douet-GuilbertService de Génétique Médicale et Biologie de la Reproduction, CHU de Brest, Brest, France.
Benjamin GanneUnit of Chromosomal Genetics and Research Platform Chromostem, Department of Molecular Genetics and Cytogenomics, Site Unique de Biologie (SUB), Montpellier CHU, Montpellier, France.
Vincent GatinoisUnit of Chromosomal Genetics and Research Platform Chromostem, Department of Molecular Genetics and Cytogenomics, Site Unique de Biologie (SUB), Montpellier CHU, Montpellier, France.
Franck PellestorUnit of Chromosomal Genetics and Research Platform Chromostem, Department of Molecular Genetics and Cytogenomics, Site Unique de Biologie (SUB), Montpellier CHU, Montpellier, France.
Aurore PerrinService de Génétique Médicale et Biologie de la Reproduction, CHU de Brest, Brest, France. aurore.perrin@chu-brest.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromothripsis and chromoanasynthesis have been described as new complex chromosomal rearrangements and are grouped under the term chromoanagenesis.Various mechanisms of formation of these rearrangements have been identified and reproduced experimentally, including the sequestration of chromosomes in micronuclei, the premature condensation of chromosomes, or abortive apoptosis. All these phenomena can occur during human spermatogenesis, particularly abortive apoptosis which leads to DNA fragmentation in spermatozoa.Given the paternal origin of most cases of chromothripsis and chromoanasynthesis, their presence is researched in human sperm samples with high DNA fragmentation rate.Magnetic-activated cell sorting (MACS) is performed on sperm samples to separate spermatozoa according to their fragmentation rate. Sorting efficiency is assessed by using the Annexin V-FITC staining and the fragmentation rate is assessed by using TUNEL (Terminal deoxynucleotidyl transferase-mediated dUTP Nick-End Labeling) assay.Pools of spermatozoa with a high DNA fragmentation rate are thus constituted, on which genomic analysis can be performed to identify complex rearrangements, such as chromothripsis and chromoanasynthesis.

Indexed as

ChromothripsisDNA FragmentationSpermatogenesisSpermatozoaApoptosisBiomarkersFlow CytometryHumansIn Situ Nick-End LabelingMaleBiomarkersChromoanagenesisChromoanasynthesisChromothripsisDNA fragmentationMACSSpermatozoaTUNEL

Identifiers

PMID40884665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.